Article
COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing.
Clinical chemistry - 1 Mar 2012
Milbury Coren A, Correll Mick, Quackenbush John, Rubio Renee, Makrigiorgos G Mike
Abstract excerpt
BACKGROUND: Despite widespread interest in next-generation sequencing (NGS), the adoption of personalized clinical genomics and mutation profiling of cancer specimens is lagging, in part because of technical limitations. Tumors are genetically heterogeneous and often contain normal/stromal cells, features that lead to low-abundance somatic mutations that generate ambiguous results or reside below NGS detection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
